tiprankstipranks
Advertisement
Advertisement
Rani Therapeutics initiates Phase 1 study of RT-114 RaniPill
PremiumThe FlyRani Therapeutics initiates Phase 1 study of RT-114 RaniPill
3M ago
Rani Therapeutics finalizes governance and capital structure changes
Premium
Company Announcements
Rani Therapeutics finalizes governance and capital structure changes
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114
Premium
Company Announcements
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114
5M ago
Rani Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe FlyRani Therapeutics assumed with a Buy at H.C. Wainwright
5M ago
Rani Therapeutics Holdings: Innovative RaniPill Platform and RT-114 Program Drive Buy Rating
Premium
Ratings
Rani Therapeutics Holdings: Innovative RaniPill Platform and RT-114 Program Drive Buy Rating
5M ago
Rani Therapeutics price target raised to $10 from $5 at Maxim
Premium
The Fly
Rani Therapeutics price target raised to $10 from $5 at Maxim
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100